English
Deutsch
Français
Nederlands
Español
Reset. Heal. Grow.
Telepathy in Ayahuasca Ceremonies: What People Actually Experience
Sit around a fire long enough with people who've drunk ayahuasca, and eventually someone brings it up. Quietly. Sideways. Almost apologetic. Did you feel that thing where I was thinking about my grandmother and then you started singing about grandmothers? Or the classic: two participants comparing notes the morning after and realising they both saw the same jaguar, in the same colours, at roughly the same hour of the night. Telepathy is the word people reach for, though most of them wince using it. It sounds ridiculous in daylight. But something happens in ceremony that a lot of ayahuasca drinkers — sceptics, engineers, therapists, people with zero interest in woo — end up trying to describe. This piece is about what that something might actually be, why it shows up so often, and what to make of it if you're weighing a plant medicine retreat and wondering whether you're signing up for something genuinely strange. Let's define the territory. When ayahuasca participants talk about telepathic communication, they usually mean one of a few distinct things, and lumping them together muddies the conversation. These are wildly different phenomena. The first two invite parapsychology debates. The third is closer to what long-term drinkers describe as the heart of the work. The fourth has plausible neurological explanations that don't require any leap at all. Ayahuasca isn't the only psychedelic where people report boundary-blurring between minds — psilocybin trips can do it, DMT breakthroughs certainly do — but the ayahuasca ceremony has some structural features that seem to amplify it. You're in the dark, usually, or near it. You're sitting in a circle with other people who are also stripped of their usual defences. There's a facilitator singing icaros, which are old melodic invocations that essentially organise the room's attention. Nobody is on their phone. Nobody is checking out. For six or eight hours, everyone in the maloca is running roughly the same software — the same neurochemistry, the same intent to look inward, the same sonic scaffolding. Under those conditions, of course people start to feel connected. The interesting question isn't whether they feel it. It's what's actually happening. Here's where I have to be honest. I've sat in enough circles to have collected a small pile of experiences that the tidy explanations above don't quite cover. A woman who described, in exact detail, a room in my childhood house she couldn't have known about. A ceremony where a friend in another country said he'd been thinking about me all night — the same night I'd apparently been thinking about him, hard, during my second cup. Are these anecdotes proof of anything? No. Anecdotes never are, and the human brain is a pattern-matching machine that will happily manufacture connections. But if you spend time in the ayahuasca world, you'll hear enough of them from enough level-headed people that dismissing the whole category starts to feel like its own kind of closed-mindedness. My working stance, for whatever it's worth: something real is happening around interpersonal perception in these ceremonies, most of it has ordinary explanations, and a stubborn residue doesn't. I don't need to resolve the residue to take the work seriously. If you're reading this because you're considering an ayahuasca retreat — for depression, for addiction, for a life pattern that won't budge — the telepathy question probably isn't your main concern. But it's worth understanding because it bears directly on what plant medicine healing actually is. A lot of what makes ayahuasca useful for addiction recovery, trauma, and psychedelic-assisted growth isn't the pharmacology alone. It's the sudden dissolution of the wall you've built between yourself and everyone else. People who've been isolated for years — by shame, by depression, by an addiction that shrinks their world down to the size of the substance — often report feeling, mid-ceremony, that they are being witnessed. Not judged. Witnessed. By the medicine, by the facilitator, sometimes by other participants without a word exchanged. Call that telepathy or don't. The effect on someone who hasn't felt truly seen in a decade can be enormous. That's part of why master plants like ayahuasca show up so often in conversations about psychedelic healing — they don't just alter perception, they alter the felt distance between self and other. Short answer: no. Longer answer: also no, and here's why. People who show up to ceremony chasing a specific phenomenon — telepathy, ego death, past-life visions, the works — reliably have worse experiences than people who show up with a genuine question and a willingness to be met wherever the medicine meets them. Ayahuasca has a way of refusing to be a vending machine. Ask for the trippy stuff and you'll often get an eight-hour lecture on your unwashed dishes and unresolved resentments. Ask for what you actually need and something else can open. If you do end up in a room where the shared-mind quality shows up, notice it, log it, don't cling to it. Talk about it in integration. And be wary of any facilitator or fellow participant who wants to build a whole cosmology out of your Tuesday-night vision. A few practical filters worth applying if this topic interests you: If the intersection of plant medicine, group ceremony, and honest inner work is what's pulling at you, there are curated ayahuasca retreats and broader psychedelic offerings you can browse on our marketplace here. Read the descriptions carefully, ask the questions above, and trust the answers that feel specific over the ones that feel poetic. Whatever the true nature of the connection people feel in ceremony — psychological, physiological, something we don't have language for yet — the fact that it happens at all is one of the reasons this work keeps drawing people back. Not for the fireworks. For the strange, quiet sense that you are, briefly, not alone in your own head.
Can Ayahuasca Really Help Me? An Honest Answer for the Skeptical Seeker
You've probably typed some version of the question into a search bar late at night. Can ayahuasca actually help me? Not the marketing version. Not the influencer version. The real answer, from someone who's sat in enough ceremonies to know that the plant is neither a miracle nor a myth. Here's what I've learned watching hundreds of people move through this work — friends, journalists, retreat guests, the occasional lawyer having a midlife reckoning. Ayahuasca can help. It can also do absolutely nothing. And in some cases it can make things messier before it makes them better. The difference usually comes down to who's asking, what they're bringing, and what they do with the experience once the brew wears off. The reasons people book an ayahuasca retreat are more repetitive than you'd think. Depression that hasn't budged after years of SSRIs. Addiction — alcohol, cocaine, porn, work, the whole menu. Trauma from childhood that keeps leaking into adult relationships. Grief that won't finish grieving. A sense of being stuck in a life that looks fine from the outside and feels dead from the inside. Occasionally someone shows up out of pure curiosity, wanting a big psychedelic experience. Those people usually get something they didn't order. The plant tends to skip over the tourist itinerary and go straight for whatever you've been avoiding. If you're in the first camp — someone genuinely suffering and looking for a way through — the honest answer is that ayahuasca has helped a meaningful number of people in situations like yours. It has also failed to help others. Both things are true, and anyone telling you otherwise is selling something. The scientific literature on ayahuasca is still young but no longer thin. Observational studies out of Brazil, Spain, and Canada have documented reductions in depression scores, reductions in problematic substance use, and improvements in measures of well-being that persist months after a single ceremony. Brain imaging work suggests the DMT-and-MAOI combination in the brew increases neural connectivity in ways that resemble — but aren't identical to — what happens with psilocybin. None of this proves ayahuasca is a treatment. Clinical trials with proper controls are still catching up. What the research does suggest is that the anecdotes aren't all lies. Something is happening. For a subset of people, that something appears to be genuinely therapeutic. The clearest signal is in addiction recovery. Multiple studies of ayahuasca in the context of alcohol and stimulant dependence have shown reductions in use — sometimes dramatic ones — following ceremonial work combined with integration. Ibogaine has a similar reputation for opioid dependence, and psilocybin-assisted therapy has strong data for tobacco cessation. Psychedelics and addiction are quietly becoming one of the most interesting stories in mental health research. Ask ten facilitators how ayahuasca heals and you'll get ten answers. Here are the ones that hold up under scrutiny. None of these mechanisms require you to buy any particular spiritual framework. You can be a hardened atheist and still get something out of the work. Many people do. This is the part most retreat websites won't tell you. There are situations where drinking ayahuasca is a bad idea, and pretending otherwise does real damage. If you have a personal or family history of psychosis, schizophrenia, or bipolar I, sit this one out. The risk of triggering a serious episode is not theoretical. Reputable retreats screen for this. Sketchy ones don't. If you're on SSRIs, MAOIs, lithium, or certain other medications, the interaction can be dangerous. Serotonin syndrome is a real thing and it can kill you. Any legitimate facilitator will ask about your medications and require a taper before ceremony, supervised by a doctor if needed. If you're in acute crisis — actively suicidal, in withdrawal, in the middle of a psychiatric emergency — a jungle retreat is not the answer. Stabilize first. Ayahuasca is more useful for people who are functional-but-stuck than for people whose lives are actively on fire. And if you're expecting the ceremony to do the work for you? You'll probably be disappointed. The plant shows you things. What you do with what you see is entirely on you. The plant medicine world has grown fast and unevenly. Some centers are staffed by lineage-trained curanderos with decades of experience and doctors on call. Others are essentially unlicensed wellness startups run by someone who did an apprenticeship on Instagram. The gap matters more than any brochure will admit. Things to look for when you're evaluating a retreat: You'll hear the phrase master plants a lot in this world, and it's worth understanding what people mean. In the Amazonian tradition, master plants are teacher plants — species considered to have their own intelligence and lessons, worked with through dieta (isolated periods of specific eating, drinking, and behavior) to build a relationship. Ayahuasca is the most famous of them, but there are dozens: chacruna, chiric sanango, bobinsana, ajo sacha, tobacco (mapacho), and others depending on the tradition. You don't have to adopt the metaphysics wholesale to take the framework seriously. What the tradition seems to know — and what a lot of Western participants eventually accept — is that these plants do something specific to consciousness, and that relating to them with respect and preparation tends to produce better outcomes than treating them like a substance to consume. Probably, if a few things are true. If you're motivated by genuine desire to change rather than curiosity or desperation. If you're medically and psychiatrically appropriate. If you choose a retreat that takes safety and integration seriously. If you're willing to do the unglamorous work in the months after the ceremony — the journaling, the therapy, the awkward conversations, the new habits — that turn insight into an actual different life. Ayahuasca is not a shortcut. It's more like an intense one-on-one with a version of yourself you've been avoiding. Whether that meeting changes anything depends on what you do next. If you're seriously considering this path, take your time choosing where to sit. A range of vetted ayahuasca ceremonies and plant-medicine retreats can be explored on our marketplace here, and the difference between the right container and the wrong one is often the difference between a hard week you remember fondly and a hard week you spend years untangling.
Working With Anger: How Plant Medicine and Practice Reshape a Difficult Emotion
Anger is the emotion nobody wants to admit they have a problem with. Sadness gets sympathy. Anxiety gets prescriptions. But anger? Anger is the one we hide, minimize, or perform depending on the room we're standing in. And for a lot of people quietly considering an ayahuasca or psychedelic retreat, anger sits closer to the center of the reason than they'd like to say out loud. I've sat in enough ceremonies — and interviewed enough people who've sat in more — to know that when the plant medicines start doing their work, anger is often the first door that opens. Not always the loud kind. Sometimes it's the quieter, older anger that's been calcified into resentment, chronic tension, or a low-grade cynicism about being alive. This is a piece about how practice — psychedelic, contemplative, or both — can change your relationship to that fire. Ayahuasca has a strange way of surfacing what you've been managing. People come in wanting to work on depression, addiction, a stalled career, a marriage that's gone quiet. What they end up meeting, more often than not, is a version of themselves that is furious about something they never named. Facilitators I trust have said the same thing in slightly different words: the brew doesn't create anger, it declassifies it. The vine — Banisteriopsis caapi, sometimes called grandmother among the master plants — has a reputation in the Amazon for teaching. And one of the first things it tends to teach is that you've been carrying weight you didn't know you were carrying. Psilocybin retreats produce a slightly different flavor of the same encounter. Ibogaine, used specifically for addiction recovery, tends to be more forensic — a long, sober-feeling review of every decision that led you into the substance you're trying to leave. Anger shows up there too, but it's often aimed inward before it turns outward. Let me be specific, because vagueness on this topic doesn't help anyone. Here's what participants commonly describe: Nobody hands you a script for this. A good facilitator will hold space, offer icaros or silence depending on what you need, and let the medicine do what it does. A bad one will try to steer the experience, which is one of the red flags to watch for when you're choosing where to go. The point isn't catharsis for its own sake. Screaming into a pillow is free. What ceremony can offer — when it works — is the chance to see the anger clearly enough to stop identifying with it. That's a different thing. Short answer: sometimes, for some people, and rarely without hard work afterward. The longer answer is worth spending a minute on, because it's one of the most common searches from people considering a retreat. Clinical research on psilocybin for alcohol use disorder and on ibogaine for opioid dependence has been genuinely interesting over the past few years. Ibogaine in particular has a striking record for interrupting withdrawal and cravings, which is why clinics in Mexico and Costa Rica see a steady stream of people who have tried everything else. Ayahuasca has a smaller but growing body of evidence around addiction, trauma, and depression — the three tend to travel together. Here's what the research and, honestly, my own conversations with people in recovery keep pointing to: the plant medicine isn't the treatment. The treatment is what you do with what the plant medicine shows you. Anger at a parent, at a former self, at a system that failed you — the ceremony can bring it into the room, but the integration is where it either becomes fuel for a new life or gets buried again. People who work with plant medicine seriously — and who put the daily-practice hours in around it — describe a shift in their relationship to anger that isn't about becoming placid. Nobody I respect claims they stopped getting angry. What they describe is more like a widening of the gap between the spark and the reaction. Some of the specific shifts they mention: None of this is instant. Anyone selling you a one-weekend transformation is selling you something. But over months and years, with practice and, for many people, a small number of well-held ceremonies, the fire changes character. It becomes information rather than identity. If you're considering booking, and anger — your own, or the anger sitting underneath your depression or your drinking or your stuckness — is a big part of what you're carrying, a few honest suggestions from years of watching this space: Look for facilitators who talk about integration as much as they talk about ceremony. If the website is all glowing testimonials and no mention of what happens after you fly home, keep looking. Ask specifically how they handle strong emotional releases in ceremony — the answer should be specific, not spiritual-sounding. Be honest on the medical intake. Anger that lives in the body often travels with high blood pressure, cardiac issues, or medications that don't mix well with MAOIs. A retreat that doesn't ask you detailed medical and psychiatric questions before accepting your deposit is a retreat that hasn't earned your trust. Give yourself real time afterward. A week back at your desk is not integration. Two or three quiet weeks, with someone to talk to who understands psychedelic experience, is closer to the minimum. Here's the part that gets underplayed in the excitement around psychedelic healing: the daily practice — sitting quietly, breathing, noticing — is what makes any of it stick. Ceremony without practice is a fireworks show. Practice without ceremony is often enough on its own. Both together is where the real work happens for a lot of people. You don't need to become a Buddhist or a shaman or anything else. You need something like ten to twenty minutes a day where you sit with yourself and notice what's actually there. Anger included. Especially anger. That's the ground the plant medicines can then plant something in. For readers who want to take this further, a curated range of ayahuasca and plant-medicine retreats — many with strong integration support built in — can be browsed on our marketplace here. Choose slowly. The right container matters more than the right destination.
Psilocybin for Treatment-Resistant Depression: What the Latest Phase 3 Data Actually Tells Us
If you've been quietly tracking psilocybin's slow march toward regulatory approval — maybe because you or someone you love has run out of options with conventional antidepressants — this month brought news worth pausing on. Compass Pathways, the London-based biotech that has been running the largest psilocybin trials on the planet, just released 26-week data from its second Phase 3 study of a synthetic psilocybin formulation in treatment-resistant depression. Regulators are watching. Investors are watching. And, more importantly for our purposes, so are the people who might one day be prescribed this stuff. Here's the short version: the trial hit its earlier six-week endpoint back in February, the six-month follow-up data has now landed, and the company is aiming for a launch in the first half of 2027. That's the headline. The more interesting story lives in the details — what the numbers actually mean, what they don't mean, and how any of this connects to the broader world of psychedelic healing that's been quietly reshaping how we think about depression, addiction, and stuck patterns. The trial in question is called COMP006. It enrolled 581 participants with treatment-resistant depression — meaning people who had already tried at least two antidepressants without meaningful relief. Participants were randomized to receive two doses of synthetic psilocybin (either 1 mg, 10 mg, or 25 mg) spaced three weeks apart, alongside psychological support. The 1 mg group functions as a low-dose comparator, which is the closest thing you can get to a placebo when the drug in question produces obvious perceptual effects. The primary endpoint — the one that mattered most for regulators — was the difference in depression scores between the 25 mg and 1 mg groups at week six, measured using the Montgomery-Åsberg Depression Rating Scale (MADRS). Compass reported a 3.8-point difference favoring the high dose. Statistically significant. Clinically meaningful? That's where the debate started, because a 3.8-point MADRS difference is on the modest end of what psychedelic-assisted therapy studies have typically shown. The new six-month data covers what happened in Part B of the study, from weeks 9 through 26. Participants could opt for a retreatment dose during this window, and — importantly — they were also allowed to start a conventional antidepressant. That last detail matters more than it sounds, and we'll come back to it. Anyone who has spent time around plant medicine circles knows the same refrain: the trip is the easy part. It's the weeks and months afterward — the integration, the follow-through, the not-slipping-back — that determines whether anything actually changes. The same principle applies here. A one-time bump in mood scores at week six is nice. Sustained improvement at six months is the number that decides whether a treatment is worth building an entire clinical infrastructure around. Long-duration data also tells regulators something about durability and safety. Does the antidepressant effect fade? Do adverse events emerge later? Do people relapse and need another dose? These are the questions the FDA cares about, and they're the questions any thoughtful person considering this route should care about too. A drug that works for a month and then wears off is a different clinical animal than one that resets something for a year. Compass has said the 26-week data supports its case for approval and that it's targeting a commercial launch in the first half of 2027. If that timeline holds — a genuinely big if, because the FDA has surprised the psychedelic industry before — psilocybin-assisted therapy would become the first classical psychedelic legally available on prescription in the United States. That's a real inflection point, not just for biotech investors but for the entire cultural conversation about psychedelics. Let's talk about the 3.8-point MADRS gap honestly, because it's the sticking point. Earlier open-label psilocybin studies produced effect sizes that made headlines — big drops in depression scores, dramatic personal testimonials, the whole cinematic package. When you move from a small, unblinded pilot to a rigorous multi-site Phase 3 with a low-dose comparator, effect sizes almost always shrink. That's not a scandal. That's how drug development works. But the shrinkage in this case was more than some observers expected. A few honest possibilities to hold at once: None of this settles the question of whether COMP360 is a breakthrough or an incremental improvement. It probably lands somewhere in the middle — a real tool, not a miracle, and more useful for some people than for others. Here's where things get interesting for readers of a plant-medicine publication rather than a biotech newsletter. The Compass trial isn't ayahuasca. It isn't a ceremony. It's a synthetic molecule delivered in a clinic with eye shades, curated music, and a licensed therapist. And yet — the underlying pharmacology is essentially identical to what mushrooms have offered humans for thousands of years. The medical framework is new. The molecule is old. For people considering a psychedelic retreat right now, the trial data has a few practical implications. First, it reinforces something ceremonial traditions have said forever: dose matters, set matters, setting matters, and integration matters more than any of them. The trials that produce the best results are the ones that take preparation and aftercare seriously. Second, the six-month durability question applies just as much to a ceremony in Peru or Jamaica as it does to a clinical trial in Ohio. If you sit with medicine and don't do the follow-through work, the window closes. Third, and this is worth saying out loud: legal, regulated access is coming, but it's coming slowly, and the retreat world will continue to serve people who can't or won't wait. If you're weighing whether to book an ayahuasca retreat, a psilocybin retreat in a legal jurisdiction, or an ibogaine program for addiction, none of the Compass news changes the fundamentals of that decision. You still need to vet the facilitators. You still need to be honest with yourself about medications, medical conditions, and mental health history. You still need a plan for what happens the week after you fly home, when the insights start to fade and the old patterns come knocking. A few things I'd still tell anyone doing this research, regardless of what the FDA does in 2027: The next twelve months will be busy in the regulated psychedelic world. Compass will submit its full data package to the FDA. Other companies working on psilocybin, MDMA, ibogaine analogues, and DMT-based therapies are watching to see how the agency responds. State-level programs in Oregon and Colorado will keep evolving. And the underground and semi-legal retreat world — which has been quietly doing this work for decades — will keep serving the people who need it now, not in 2027. What's genuinely worth celebrating, whether or not you personally would ever step into a clinic for psilocybin therapy, is that a serious drug regulator is now looking at classical psychedelics as legitimate medicines. That's a shift. Ten years ago it was unthinkable. Today it's an earnings-call talking point. The cultural rehabilitation of these compounds — the master plants, if you want the older language — is happening in real time. If any of this has your attention and you're thinking seriously about doing the work in a ceremonial or retreat setting rather than waiting for a pharmacy, a curated selection of psilocybin and broader plant-medicine retreats can be browsed on our marketplace here. Whatever route you choose, choose it carefully, and give it the respect it deserves.
Blocked by the Algorithm, Not the Medicine: Notes on Finding Real Ayahuasca Info Online
You go looking for a straight answer about ayahuasca, and instead you hit a wall. A login prompt. A paywall. A subreddit that wants you to prove you're a real person before it shows you a piece of art someone made about their ceremony. Anyone who has spent a few weeks researching plant medicine online knows the feeling — half the good stuff is behind a gate, and the other half is either sales copy or someone's third-hand horror story. So let's skip the gatekeeping and talk about what a person actually needs when they're deciding whether to sit with ayahuasca. Not the mystical version. Not the fear-mongering version. The version a friend would give you if they'd been through it and had no reason to lie. Part of the problem is legal. Ayahuasca sits in a strange grey area in most of the world — protected for religious use in a handful of countries, tolerated in others, and outright illegal in a lot of them. Publications get skittish. Platforms shadow-ban. Forums lock down to keep out the curious tourists and the DEA bots. The result is a fractured landscape where the most useful voices — experienced facilitators, honest retreat alumni, harm-reduction workers — are the hardest to hear. The other part is commercial. There's real money in psychedelic retreats now, and where there's money, there's marketing. Beautifully shot websites promise transformation, healing, and awakening. Some of those retreats are excellent. Some are run by people who read a book last year and bought a maloca. Telling them apart from a Google search is genuinely difficult, which is why so many first-timers end up asking the same questions in the same locked forums, over and over. What follows is the stuff I wish I'd had in a single place before my first ceremony. No login required. The honest answer is: it depends. On the brew, the facilitator, your body chemistry, what you ate that week, what you didn't process at your last therapy session, and things that no one can predict. But there are patterns. Most ceremonies happen after sundown in a ceremonial space — often a circular thatched building called a maloca. You drink a small cup of a bitter, tar-like tea. Then you wait. Somewhere between 20 minutes and an hour later, the medicine arrives. For some people that means visions — geometric patterns, animals, memories they'd forgotten they had. For others it's more somatic: waves of emotion, physical sensations, purging (which is the polite word for vomiting, and which is considered part of the healing, not a side effect to be embarrassed about). The whole thing lasts four to six hours. There's usually singing — icaros, the traditional songs of the Amazonian curanderos — which serve as a kind of navigational aid through the experience. When it's over, you sleep. You wake up different. Sometimes only slightly. Sometimes profoundly. This is where most of your research energy should go. A good retreat can be life-changing. A bad one can be dangerous. The stakes are real, and the vetting process is not glamorous — it's mostly reading, emailing, and asking uncomfortable questions. Here's what to actually look for: Reviews help, but read them carefully. Someone who had a peak experience will rave. Someone who had a hard time may blame the retreat when the difficulty was actually the medicine doing its job. Look for detail. Vague ecstatic reviews and vague furious reviews are both worth less than a careful, specific account. A lot of the people who write to me quietly, off the record, are asking the same underlying question. They're not sure they can say it out loud. They want to know whether ayahuasca — or ibogaine, or psilocybin, or any of the master plants — can help them stop drinking, stop using, stop the pattern they can't stop themselves. The honest answer: sometimes, yes. There's a real and growing body of research on psychedelic-assisted recovery, and the anecdotal reports from people who've broken decades-long addictions after plant medicine work are not nothing. Ibogaine in particular has an unusual track record with opioid dependence. Ayahuasca has helped people with alcohol use disorder, cocaine dependence, and the tangled web of trauma that so often sits underneath addiction. But it's not a magic wand. The medicine shows you things. What you do with those things — the therapy, the sober community, the practices you build around your recovery — is what makes the change stick. People who go into a retreat expecting a one-shot cure often relapse. People who go in treating the retreat as one significant step in a longer, harder process tend to do better. If you're considering plant medicine specifically for addiction, be extra rigorous about the retreat you choose. Some centers specialize in recovery work and have staff trained in it. Others don't, and pretending otherwise is dangerous. A week-long ayahuasca retreat in Peru or Costa Rica typically runs anywhere from $1,200 on the low end to $4,000 or more for the well-established centers. Add flights, time off work, and the two-week dieta most retreats ask you to follow beforehand (no alcohol, no red meat, no recreational drugs, sometimes no sex or caffeine). It's not a casual purchase. The non-financial costs are real too. You will spend hours confronting things you've spent years avoiding. You may cry for a whole afternoon. You may feel physically wrecked for a day or two. You may come home and realize the job or the relationship you were in doesn't fit anymore, and you'll have to decide what to do about that. Nobody warns you about that part often enough. That's not a reason not to go. It's a reason to go with your eyes open. If you've been researching this for weeks or months, you already know something in you is asking for it. That doesn't mean you should book the first retreat you find. It means the question is worth taking seriously — slowly, with real information, and ideally in conversation with people who've done the work and can speak plainly about it. Talk to alumni. Talk to your therapist if you have one. Read what you can find that isn't hidden behind a login screen. And when you're ready to compare specific options, a curated selection of ayahuasca ceremonies and plant-medicine retreats can be browsed on our marketplace here. Take your time with it. The medicine, as the curanderos say, has been waiting a long time. It can wait a little longer while you choose well.
Craving More Stories?
Join our ShopAyahuascaRetreats newsletter for the latest updates on thrilling
destinations and inspirational tales, delivered straight to your inbox!
We value your privacy. Your email address will never be shared or published.
Choosing an Ibogaine Retreat in Mexico: What to Actually Look For
Someone messages me about once a week asking the same question in slightly different words: I'm thinking about doing an ibogaine retreat in Mexico — how do I know which one is legit? It's a fair question, and honestly one of the more important ones a person can ask before handing over a few thousand dollars and their nervous system to strangers in a foreign country. Ibogaine is a serious plant medicine. Not the kind you dabble with on a long weekend because you saw a podcast. It's been used for decades to interrupt opioid dependence, and increasingly for alcohol, stimulants, trauma, and the kind of stuck life patterns that talk therapy alone hasn't touched. Mexico has become the de facto capital of ibogaine treatment because the substance is unscheduled there — which means clinics operate openly, but it also means quality varies wildly. Some places are staffed by cardiologists and addiction specialists. Others are one guy with a rented villa and a WhatsApp number. So let's talk about how to tell the difference. In the United States, ibogaine sits on Schedule I, which means it can't be legally administered outside of research contexts. Canada is similarly restrictive. Mexico never scheduled it, and neither did most of Central America. Over the past twenty years, a small industry of ibogaine providers has grown up along the Baja peninsula, around Cancún and Playa del Carmen, and in cities like Tijuana, Rosarito, and Puerto Vallarta. The upside: real medical treatment with a psychedelic that has genuine evidence behind it for addiction recovery. Studies out of New Zealand, Brazil, and independent researchers have documented significant reductions in opioid withdrawal and long-term abstinence rates after a single ibogaine session. That's not a small thing when you're talking about a drug crisis that kills more Americans each year than car accidents. The downside: no federal Mexican body regulates ibogaine clinics the way, say, the FDA regulates a US hospital. Which means the burden of due diligence falls on you. Here's the part reputable providers will bring up immediately and sketchy ones will gloss over: ibogaine can be cardiotoxic. It prolongs the QT interval on an EKG, which in plain English means it can trigger dangerous arrhythmias in people with underlying heart conditions. People have died from ibogaine sessions. Not many, statistically — but enough that any center worth its fee will require, at minimum: If a retreat waves off any of these, walk away. I don't care how good their Instagram looks or how many testimonials they have. The people who died from ibogaine largely died because someone skipped the screening. You can't tour the facility in person before you commit, most of the time. So the vetting happens on video calls, forums, and phone conversations. Here's what I'd actually do: Expect to pay somewhere between $5,000 and $12,000 USD for a legitimate program, depending on length, medical intensity, and location. The higher end usually includes more medical infrastructure, longer stays (7–10 days versus 3–5), and structured integration. If you find a place quoting $2,000, be suspicious. Ibogaine, done properly, involves an EKG-monitored dose over 24–36 hours, IV access, a private room, and a medical team on standby. That doesn't happen cheaply. The cheap places are cutting corners somewhere, and with this particular medicine, the corners you cut can kill you. On the other hand, $20,000-plus luxury programs are often paying for the villa, not better medicine. A stainless steel clinic in Rosarito with a cardiologist on-call is safer than a beachfront palace with a “shaman” and no crash cart. Pretty views don't stabilize an arrhythmia. People searching for what ibogaine feels like get a lot of mystical language online. Let me try to be plainer. After the initial dose, most people feel a buzzing or ringing in the ears, a sense of the world tilting slightly, and then — usually within an hour — the visionary state begins. It's less like a psilocybin trip and more like being pinned inside a rapidly cycling autobiographical film. You may see memories, ancestors, moments you'd forgotten, versions of yourself you avoid. It goes on for a long time. Twelve to twenty-four hours of active experience isn't unusual, followed by another day or two of what people call the "gray day" — a flat, contemplative afterglow where you feel wrung out but oddly clear. Most people don't get up and dance. Most people lie very still and process. Physical side effects are real: nausea (they'll give you an anti-nausea med, usually), ataxia (you literally can't walk safely — you'll need help to the bathroom), and sometimes intense body sensations. This is not a party drug. It's a demanding, uncomfortable, often profound experience that happens to sometimes reset the neurochemistry of addiction. Honest answer: it depends what you're bringing to it. Ibogaine has the strongest evidence for opioid dependence — people getting off heroin, fentanyl, prescription painkillers, or long-term methadone use. It's also been used successfully for alcohol, cocaine, and methamphetamine, though with somewhat more variable outcomes. And there's a growing cohort using it for PTSD, complex trauma, and depression that hasn't responded to conventional treatment. It's probably not right for you if: That last one matters more than people admit. Ibogaine can crack something open. It can also close back up if you go home to the same apartment, the same relationships, and the same nightly bottle of wine. The medicine gives you a window. What you do with the window is on you. Get travel insurance that covers medical evacuation. Bring a trusted person if you can — someone who'll be at the retreat but not dosing, or at minimum someone who knows exactly where you are and when to expect a call. Tell your regular doctor at home what you're doing, even if you think they'll disapprove. If something goes wrong medically after you return, they need to know what you took. Give yourself real time on the other side. Don't fly home and go back to work on Monday. Ibogaine sessions often leave people insomniac for days, emotionally raw for weeks, and quietly rearranging their lives for months. Plan for that. Book time off. Line up a therapist or integration coach before you leave. For readers who want to explore what's out there, curated ibogaine and plant-medicine retreats can be browsed on our marketplace here — a starting point for the kind of side-by-side comparison that's hard to do from a Google search alone. Whatever you choose, choose slowly. This is one of those decisions where the extra week of research pays for itself many times over.
Who Shouldn't Take Ibogaine? Medical Conditions That Rule You Out
Here's something most ibogaine marketing pages bury near the bottom, if they mention it at all: this medicine can kill you. Not in a scary-story sense. In an actual, documented, cardiac-arrest sense. Ibogaine is one of the most promising tools we have for interrupting opioid addiction and shaking loose stubborn patterns of trauma — and it's also the psychedelic with the most serious medical contraindications. If you're researching whether ibogaine is right for you, understanding who shouldn't take it matters more than reading another glowing testimonial. This isn't meant to scare anyone off. Plenty of people go through ibogaine safely every year, and for some, it's genuinely life-changing — especially those looking at plant medicine for addiction after years of trying everything else. But the difference between a safe experience and a medical emergency often comes down to screening. So let's talk about what actually disqualifies people, why, and what a responsible clinic looks like on the intake side. Ayahuasca, psilocybin, San Pedro — these master plants carry their own risks, but they don't typically stress the cardiovascular system the way ibogaine does. Ibogaine has a direct effect on the heart's electrical activity. Specifically, it prolongs something called the QT interval, which is the time your heart's ventricles take to reset between beats. Prolong it too much and you're looking at a dangerous arrhythmia called torsades de pointes, which can be fatal. That's the mechanism behind most of the deaths that have occurred in ibogaine settings over the past few decades. Not the visions. Not the purge. The heart. So when a reputable clinic asks you for an EKG, blood work, and a full medication list, they're not being paranoid — they're being competent. The other thing worth knowing: ibogaine has a long half-life. A typical flood dose keeps you in an altered, physically demanding state for anywhere from 24 to 36 hours, with residual effects lingering for days. If something goes wrong medically at hour 18, you can't just wait it out. That's why the trend among serious providers has shifted toward medical-model clinics with cardiac monitoring, IV access, and staff who can actually intervene. Cardiac issues are the number one reason people get turned away from legitimate ibogaine programs. If any of the following apply to you, most responsible clinics will decline to treat you — and the ones that won't decline are the ones you should worry about. Some of these can be worked around with additional testing and cardiology clearance. Others are absolute stops. A borderline QT reading might get you retested; a documented arrhythmia probably won't. If you're over 40 or have any risk factors, expect the clinic to want a recent EKG and often an echocardiogram before they'll even schedule you. This is where things get complicated, because a huge number of common prescriptions either prolong QT themselves or interfere with the liver enzymes that metabolize ibogaine. The stack effect can be brutal. SSRIs and SNRIs — the entire class of common antidepressants including sertraline, fluoxetine, escitalopram, venlafaxine, duloxetine — are a significant concern. Most reputable providers require a taper of several weeks before treatment. This is not optional and not something to fudge on your intake form. Combining serotonergic medications with ibogaine can trigger serotonin syndrome, which is its own medical emergency layered on top of the cardiac risk. Other medication categories that raise red flags: The methadone situation deserves its own mention because it trips up so many people seeking ibogaine specifically for opioid addiction. Methadone stores in your tissues and comes out slowly. Attempting ibogaine while still on methadone or too soon after stopping it dramatically raises the cardiac risk. Any clinic willing to treat you the week after your last methadone dose is not a clinic you want to be at. Beyond heart issues and medications, several other conditions can rule someone out or require significant additional screening: Age itself isn't a hard cutoff, but most clinics get more cautious past 55 and much more cautious past 65. The heart just doesn't tolerate the stress as reliably. Some clinics won't treat anyone over 65 regardless of test results. If you've made it this far in your research, you're already ahead of most people. Now the question becomes: how do you tell the safe providers from the reckless ones? A few honest signals to look for: A clinic that says “we'll figure it out when you get here” is not a clinic. It's a liability. And unfortunately, that describes more ibogaine operations than the community likes to admit — particularly in places where medical oversight is loose and the market is booming. Getting turned down for ibogaine is disappointing, especially if you've been circling the idea for a long time and you've read the stories about opioid interruption. But it's not the end of the road for anyone considering psychedelic healing for addiction or trauma. Ayahuasca doesn't carry the same cardiac profile, though it has its own MAOI-related medication conflicts. Psilocybin therapy — increasingly available in legal settings — has one of the cleanest safety profiles of any psychedelic. Ketamine-assisted therapy is legal, medically supervised, and effective for depression and some addiction patterns. Even conventional treatments like naltrexone or extended residential care have real evidence behind them and don't require betting on your QT interval. The point isn't that ibogaine is the only door. It's a powerful door for people it fits, and a dangerous one for people it doesn't. Being told no by a good clinic is a form of care. For anyone still weighing this decision and wanting to see what responsibly run programs actually look like, a curated selection of ibogaine and other plant medicine retreats can be browsed on our marketplace here. Take your time with it — the right treatment, at the right place, at the right moment in your life, is worth waiting for.
Ibogaine and Federal Research: Where the U.S. Actually Stands Right Now
Ibogaine has been the quiet outsider of the psychedelic conversation for decades. Ayahuasca gets the documentaries. Psilocybin gets the clinical trials and the glossy magazine covers. But ibogaine — the alkaloid pulled from a shrub in Gabon called Tabernanthe iboga — keeps forcing its way back into the discussion because of one stubborn fact: it appears to interrupt opioid addiction in a way nothing else quite does. And now, for the first time in a long time, there are actual signals from Washington that federal research money might flow toward studying it. If you're a person reading this because you or someone you love is drowning in opioids, alcohol, or stimulants — and you've started wondering whether plant medicine could really do what people online claim — this is a good moment to get oriented. Not hyped. Oriented. Ibogaine is one of several psychoactive compounds inside the root bark of iboga, a plant used ceremonially for centuries by the Bwiti people of Central Africa. In the traditional context, it's an initiation medicine — long, difficult, sacred. In the Western context, it got noticed in the 1960s after a young man named Howard Lotsof took it recreationally and realized, mid-experience, that his heroin cravings had vanished. He spent the rest of his life trying to get anyone to take that observation seriously. Pharmacologically, ibogaine is unusual. It hits multiple receptor systems — serotonin, dopamine, sigma, NMDA, opioid — and its main metabolite, noribogaine, stays in the body for days after the acute experience ends. That long tail seems to be part of why people describe the post-ibogaine window as a genuine reset rather than a comedown. Cravings that had felt like gravity for years often report as simply gone. Not cured — gone in the moment, with real work still to do. The trip itself, if you want to call it that, is nothing like ayahuasca or mushrooms. Most participants describe a long, dreamlike review of their own life — memories, decisions, patterns — often accompanied by nausea, ataxia, and a heart that needs to be monitored carefully. It's less a spiritual fireworks show and more a forensic audit. For years, the ibogaine story lived in a strange corner of the internet: veterans returning from clinics in Mexico saying their PTSD had lifted, opioid users in recovery forums swearing it had saved their lives, and a handful of scientists who refused to let the data disappear. The rest of the establishment mostly looked away, partly because ibogaine is a Schedule I substance in the U.S. and partly because it carries real cardiac risk that can't be waved off. What's shifted is the sheer scale of the overdose crisis. When more than a hundred thousand Americans a year are dying from drug overdoses, the political calculus around “we can't even study this” starts to crack. Texas moved first, allocating serious state money toward ibogaine research through a public-private partnership. Kentucky flirted with the idea. Bipartisan interest at the federal level has been building — because addiction, uniquely among health crises, tends to touch every zip code and every party. Recent legislative activity has proposed directing federal agencies to formally study ibogaine's potential in treating opioid use disorder and traumatic brain injury, particularly among veterans. That's the specific wedge being used: veterans. It's harder for a politician to argue against research aimed at people who served, and the reports from veterans who've traveled abroad for treatment have been consistent enough to be difficult to dismiss. Here's the honest answer: probably slower than the headlines suggest. A bill authorizing study is not the same as a bill funding treatment, and neither is the same as ibogaine being legal or accessible inside the United States. The realistic path looks something like this: Meanwhile, the treatment itself continues to happen — legally in a handful of countries (Mexico, Costa Rica, Portugal, New Zealand under strict conditions, parts of Brazil), and quietly in underground settings inside the U.S. that most experienced people would not recommend for a substance with genuine cardiac risk. If you're reading this because the federal news made you wonder whether you should wait for legal U.S. access or look at retreats abroad, a few honest thoughts. First, ibogaine is not a casual decision. It's not “let's try mushrooms and see how it goes.” It requires medical screening — a proper cardiac workup, EKG, liver function tests, and a serious conversation about every medication and supplement you're on. Reputable clinics will not admit you without this. If a place is willing to skip the screening, that's the loudest possible red flag. Second, ibogaine works best when it's aimed at something specific. People who go in with a clear intention — usually breaking an opioid, alcohol, or stimulant dependency, or addressing a specific trauma — tend to report more coherent outcomes than people going in for general “healing.” The medicine is directive; it responds well to being asked a real question. Third, integration is not optional. The window after ibogaine — the days and weeks when cravings are quiet and old patterns feel loosened — is when the actual rebuild has to happen. Therapy, community, changed environment, sometimes medication-assisted treatment as a bridge. People who treat ibogaine as the whole answer usually relapse. People who treat it as an opening tend to do better. The quality gap in the ibogaine world is enormous. On one end you have medically supervised clinics with cardiologists on staff, structured pre-screening, and integration support that lasts months. On the other, you have someone dosing people in an Airbnb. The difference is not marketing polish — some sketchy operations look slick. Ask specific questions: An operator who welcomes those questions is probably worth considering. An operator who dodges them is not, no matter how compelling the founder's personal story sounds. What's actually happening in American drug policy right now is a slow, uneven thaw. Psilocybin therapy is legal in Oregon and Colorado under regulated frameworks. MDMA came within a whisker of FDA approval and will get there eventually. Ayahuasca operates through religious exemptions. And ibogaine — the strangest, riskiest, and arguably most powerful of the group when it comes to addiction — is finally getting its turn at the table. If you're weighing this decision, the federal news is worth knowing but not worth waiting on. Legal U.S. access is years away at minimum. In the meantime, people are still dying of opioid overdose at rates that make the calculus of “wait for perfect research” look grim. That doesn't mean rush into a clinic tomorrow. It means do the reading, do the medical prep, and choose your setting with the seriousness that a Schedule I substance with real cardiac profile deserves. For readers who want to take this further, a range of vetted ibogaine and plant-medicine retreats can be explored on our marketplace here. Whatever you decide, decide it slowly and with better information than the internet usually provides.
Bobinsana: The Amazonian Master Plant of the Heart Explained
The first time I heard a curandero mention bobinsana, he tapped his chest twice and smiled. “Plant of the heart,” he said, and moved on to something else. That was it. No dramatic explanation. In the Amazon, the most important plants often get introduced this way — a single phrase, a gesture, and the rest is left for you to discover through the work itself. If you've been sent a bottle of bobinsana tincture, or you're looking at a retreat that offers her as part of an ayahuasca dieta, you probably want more than a shrugged “plant of the heart.” Fair enough. Here's what she actually is, what people report from working with her, and how she fits into the broader world of master plants and psychedelic healing. Bobinsana (Calliandra angustifolia) is a shrub that grows along the riverbanks and floodplains of the western Amazon — Peru, Ecuador, Colombia, Bolivia. She's easy to spot when she's flowering: soft pink pom-pom blossoms hanging over the water like something out of a Dr. Seuss book. The mestizo shamans of the Ucayali and the Napo have used her for generations, mostly the bark and the roots, prepared as a decoction, a macerado in aguardiente, or included in longer master-plant dietas. She's not a psychedelic in the sense that ayahuasca or psilocybin is. Drinking a cup of bobinsana tea will not send you tumbling through geometric visions. What she does is subtler, and that subtlety is the whole point. In the Shipibo and mestizo traditions, bobinsana belongs to a category of plantas maestras — master plants — whose job is to teach, not to entertain. You take her over time. She works on you slowly. Chemically, researchers have found flavonoids, sterols, and some minor alkaloids in the plant, but nothing that would explain her reputation on pharmacology alone. Which is, honestly, how it goes with most master plants. The action is real; the mechanism is not neatly mapped. Ask ten people who've dieted bobinsana what she does and you'll get ten variations on the same theme: she softens something. Chest opens up. Old grief that had been sitting there quietly for a decade suddenly has permission to move. People cry easily on bobinsana. Not in a bad way — more like the way you cry when you finally sit down after a long day and someone asks how you're actually doing. Here are the effects that come up again and again in participant reports and facilitator interviews: Curanderos will tell you she's particularly useful for grief, for heartbreak, for people whose life has become a project rather than a lived thing. Whether you take that literally or as a poetic frame, the pattern in reports is consistent enough to be worth taking seriously. Most people encounter bobinsana in one of three ways. The first is at home — a tincture arrives in the mail, and they take a dropperful before bed and see what shows up in their dreams. The second is as an isolated master-plant dieta, usually eight to thirty days in a jungle tambo, drinking her daily under strict food and behavioural restrictions. The third is as an addition inside an ayahuasca retreat — the maestro adds her to the brew, or gives her separately during the days between ceremonies. The traditional dieta is where her reputation really comes from. You eat plainly — no salt, no sugar, no oil, no pork, no spice — and you avoid sex, strong emotions, television, and confrontation. Just you, a hammock, the plant, and the jungle. In this container, over days, the plant does its teaching. People come out of a bobinsana dieta describing a shift they can't quite put into words, only that something in the chest has loosened. If you're considering a retreat that features her, ask the facilitators specifically how she's used. There's a real difference between a place that grows her on-site and prepares her with intention, and a place that added her to the brochure because master plants sell. A reputable maestro will be able to tell you where the plant came from, how it was prepared, and why it's being offered to you specifically. Vague answers are a red flag. Bobinsana has a mild reputation and no known serious toxicity in traditional doses, but “mild” is not the same as “ignore the details.” A few practical points: None of this is meant to scare you off. It's meant to help you take her seriously, which is what she seems to ask of the people who work with her. The current wave of interest in ayahuasca, psilocybin, and other psychedelics tends to focus on the big, dramatic experiences — the breakthrough journey, the mystical peak, the addiction interrupted in a single night. That framing has real merit; the research on plant medicine for addiction and depression is genuinely exciting. But it also misses something the Amazonian traditions have been quietly saying for a long time: the big medicines work better when they're supported by the small ones. Master plants like bobinsana, chiric sanango, ajo sacha, mucura, and piñon colorado are the quiet architecture underneath the ayahuasca experience. They prepare the body. They soften the heart. They give the ceremony something to work with. A person who has spent a couple of weeks in dieta with bobinsana tends to have a very different ayahuasca experience than someone who arrived from the airport that afternoon. This is worth sitting with if you're researching a retreat. The presence — or absence — of a real master-plant tradition is one of the more honest ways to distinguish a serious center from a fast-turnaround operation. Ask about the dietas. Ask which plants they work with and why. The answers will tell you a lot. So: the bottle is on your kitchen counter, and you're wondering what to do. A few unglamorous suggestions. Start low. Three to five drops in a little water, once a day, in the evening. Keep a notebook by the bed and write down your dreams the moment you wake up, even the fragments. Notice how your chest feels — not as a chakra concept, just physically, in the place where your ribs meet. Notice whether people irritate you less or more than usual. Notice what wants to be cried about. Don't mix her with other new supplements in the same week. Don't drink heavily while you're with her — she doesn't like it and neither will you. Give her at least two or three weeks before deciding whether she's doing anything, because subtle plants take time to show themselves. And if the pull grows stronger — if you find yourself curious about a proper dieta or an ayahuasca ceremony where she's part of the work — that's the plant doing what she does. For readers who want to take this further, curated ayahuasca and master-plant retreats where bobinsana is part of the traditional dieta can be browsed on our marketplace here. Whatever you decide, take her seriously and take your time. She rewards both.
Preparing for Ayahuasca: What to Do in the Weeks Before Ceremony
Most people spend more time researching which ayahuasca retreat to book than they spend preparing themselves to actually drink it. That's backwards. The ceremony is roughly twelve hours of your life. The preparation — and what comes after — is where the real work sits, and it's the part nobody wants to talk about because it isn't photogenic. I've sat with facilitators who've been running ceremonies for twenty-plus years, and the ones I trust most say the same thing: how you show up matters more than which shaman pours your cup. Ayahuasca isn't a magic trick performed on you. It's a mirror held up to whatever you brought with you. Bring a chaotic, unprepared nervous system, and you'll get a chaotic, unprepared ceremony. Bring something quieter, cleaner, more honest — and the medicine has room to work. So here's what preparation actually looks like when you strip away the Instagram version of it. Ayahuasca is a psychoactive brew containing DMT and MAO inhibitors, and those MAOIs are the reason the dieta exists. Certain foods and medications interact badly — sometimes dangerously — with MAOIs. This isn't a wellness suggestion. It's pharmacology. Aged cheeses, cured meats, fermented foods, and specific antidepressants (SSRIs especially) can cause serotonin syndrome or hypertensive reactions when combined with the brew. Any legitimate retreat will send you a pre-arrival protocol covering this. If the place you're looking at doesn't ask about your medications, doesn't provide a dietary list, and doesn't request a medical intake form — cross it off your list. That's a red flag, not a small one. Beyond the pharmacology, preparation does something else: it signals to your own psyche that you're taking this seriously. Two weeks of eating clean, sitting quietly, and paying attention tells your unconscious that something significant is coming. By the time you arrive, you're already halfway into the process. Traditional Amazonian dieta is stricter than what most Western retreats ask of you, but the modern short-form version still matters. Aim to start at least two weeks out, ideally longer. The pharmacological ones (aged foods, alcohol, specific medications) are non-negotiable safety issues. The rest is about arriving with a body that isn't fighting itself. If you show up bloated, hungover, and sugar-crashed, you'll spend the first half of your ceremony processing your Tuesday burrito instead of your actual life. This is where honest preparation gets uncomfortable. If you're on an SSRI, SNRI, MAOI, or tricyclic antidepressant, you cannot safely drink ayahuasca without a medically supervised taper. Full stop. The interaction risk is real and can be fatal in rare cases. Most reputable retreats require an SSRI washout of four to six weeks minimum. Some medications (fluoxetine/Prozac, with its long half-life) require longer. This is not something to negotiate with the retreat coordinator or fudge on the intake form. People have been hospitalised — and worse — because they lied on that form. Talk to your prescriber. Yes, they may not know much about ayahuasca specifically, but they understand MAOI interactions, and they can help you taper safely. If you're not willing or able to come off your medication, that's important information. It might mean this particular medicine isn't the right fit right now, and that's a legitimate answer. Psilocybin retreats, for instance, don't carry the same MAOI risk profile — though they still have their own contraindications. Here's where I part ways with a lot of the online advice. You don't need to become a meditation master before your first ceremony. You don't need to have processed your childhood in therapy. You don't need a spiritual practice. What actually helps: The people who struggle most in ceremony tend to arrive with either zero preparation or a rigid checklist of expectations. Somewhere between those two is honest curiosity, and that's what you want. Ayahuasca is not going to hand you your life's meaning on a silver tray. It might. But planning on it is a good way to be disappointed. What tends to actually happen: you feel physically uncomfortable for a while. You might purge — sometimes vomiting, sometimes shaking, sometimes crying, sometimes all of it. You may see visuals, or you may not. Some people have a night where nothing much seems to happen, and then a week later they realise something quietly shifted. Others have a full technicolour experience and then struggle to integrate it for months. Master plants — the umbrella term traditional practitioners use for ayahuasca, San Pedro, tobacco, and other teacher plants — don't run on your schedule. They work in their own time. This is where a lot of Western retreat-goers get frustrated, because we're wired to expect deliverables. There are no deliverables. There's just what the medicine gives you, which may not be what you asked for and may take months to fully understand. Booking a retreat without a plan for integration is like paying for surgery and skipping the recovery. Whatever comes up in ceremony — memories, insights, unresolved grief, buried patterns — has to land somewhere in your ordinary life. That's the hard part. Before you leave for your retreat, line up: The insight from ayahuasca fades faster than you'd expect. Writing it down in the days immediately after is how you keep it. So is talking about it, carefully, with someone qualified to hold that conversation. You can tell a lot about a retreat by how they handle you before you arrive. Signs of a place worth trusting: a thorough medical intake, a dietary and pharmaceutical protocol sent weeks in advance, a pre-arrival call with a facilitator, clear communication about what medications disqualify you, and — critically — integration support after you leave, not just during the retreat. Signs to walk away: no medical screening, vague answers about the lineage of the facilitator, pressure to book quickly, promises of specific outcomes, or a facilitator who calls themselves a shaman without traceable training. The plant medicine world has its share of well-meaning amateurs and, unfortunately, its share of predators. Preparation on their end is as important as preparation on yours. For readers who want to take this further, a range of vetted ayahuasca and plant-medicine retreats can be browsed on our marketplace here. Preparation isn't the exciting part. It's the part where you sit with your own life for a few weeks before letting a very old medicine sit with you. Do it properly, and the ceremony has something to work with. Skip it, and you're just drinking a bitter cup in the jungle hoping for the best.
Dreaming of a Psychedelic Retreat?
We have the best deals and offers from thousands of organizers all over the world! Get them into your mailbox every week!
We value your privacy. Your email address will never be shared or published.
